Microtubule affinity regulating kinase 4 (MARK4) has been reported to play a crucial role in the regulation of NLRP3 inflammasome activation7,8 and may be a potential target for hyperglycaemia-mediated NLRP3 inflammasome activation and endothelial inflammation. Here, MARK4 is linked to Hyperglycemia.